Neosporin First Aid Antibiotic Ointment

Neosporin is a well-known brand of topical antibiotic ointment used for preventing infection in minor cuts, scrapes, and burns. It was originally developed in the 1950s by the Burroughs Wellcome company. The product typically contains three different antibiotics—bacitracin, neomycin, and polymyxin B—which led to its widespread adoption as a household first aid staple.

Over the decades, ownership of the brand transitioned through several corporate mergers, moving from Burroughs Wellcome to GlaxoWellcome, and eventually to Pfizer's consumer healthcare division. In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business, bringing Neosporin into its portfolio.

Starting in 2023, as part of a significant corporate restructuring, Johnson & Johnson spun off its consumer health division into a new independent company called Kenvue. As of 2024 and looking toward 2026, Kenvue is the ultimate owner of the Neosporin brand. While the brand remains headquartered in the United States, manufacturing is distributed across various global facilities to meet international demand.